145 related articles for article (PubMed ID: 15953360)
1. Nuclear translocation of the SRF co-activator MAL in cortical neurons: role of RhoA signalling.
Tabuchi A; Estevez M; Henderson JA; Marx R; Shiota J; Nakano H; Baraban JM
J Neurochem; 2005 Jul; 94(1):169-80. PubMed ID: 15953360
[TBL] [Abstract][Full Text] [Related]
2. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.
Cen B; Selvaraj A; Burgess RC; Hitzler JK; Ma Z; Morris SW; Prywes R
Mol Cell Biol; 2003 Sep; 23(18):6597-608. PubMed ID: 12944485
[TBL] [Abstract][Full Text] [Related]
3. The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor.
Liu HW; Halayko AJ; Fernandes DJ; Harmon GS; McCauley JA; Kocieniewski P; McConville J; Fu Y; Forsythe SM; Kogut P; Bellam S; Dowell M; Churchill J; Lesso H; Kassiri K; Mitchell RW; Hershenson MB; Camoretti-Mercado B; Solway J
Am J Respir Cell Mol Biol; 2003 Jul; 29(1):39-47. PubMed ID: 12600823
[TBL] [Abstract][Full Text] [Related]
4. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
Schmidt LJ; Duncan K; Yadav N; Regan KM; Verone AR; Lohse CM; Pop EA; Attwood K; Wilding G; Mohler JL; Sebo TJ; Tindall DJ; Heemers HV
Mol Endocrinol; 2012 May; 26(5):716-35. PubMed ID: 22456196
[TBL] [Abstract][Full Text] [Related]
5. Tech: a RhoA GEF selectively expressed in hippocampal and cortical neurons.
Marx R; Henderson J; Wang J; Baraban JM
J Neurochem; 2005 Feb; 92(4):850-8. PubMed ID: 15686487
[TBL] [Abstract][Full Text] [Related]
6. Actin dynamics control SRF activity by regulation of its coactivator MAL.
Miralles F; Posern G; Zaromytidou AI; Treisman R
Cell; 2003 May; 113(3):329-42. PubMed ID: 12732141
[TBL] [Abstract][Full Text] [Related]
7. Muscle-specific signaling mechanism that links actin dynamics to serum response factor.
Kuwahara K; Barrientos T; Pipes GC; Li S; Olson EN
Mol Cell Biol; 2005 Apr; 25(8):3173-81. PubMed ID: 15798203
[TBL] [Abstract][Full Text] [Related]
8. Mutant actins that stabilise F-actin use distinct mechanisms to activate the SRF coactivator MAL.
Posern G; Miralles F; Guettler S; Treisman R
EMBO J; 2004 Oct; 23(20):3973-83. PubMed ID: 15385960
[TBL] [Abstract][Full Text] [Related]
9. OTT-MAL is a deregulated activator of serum response factor-dependent gene expression.
Descot A; Rex-Haffner M; Courtois G; Bluteau D; Menssen A; Mercher T; Bernard OA; Treisman R; Posern G
Mol Cell Biol; 2008 Oct; 28(20):6171-81. PubMed ID: 18710951
[TBL] [Abstract][Full Text] [Related]
10. Induction of megakaryocyte differentiation drives nuclear accumulation and transcriptional function of MKL1 via actin polymerization and RhoA activation.
Smith EC; Teixeira AM; Chen RC; Wang L; Gao Y; Hahn KL; Krause DS
Blood; 2013 Feb; 121(7):1094-101. PubMed ID: 23243284
[TBL] [Abstract][Full Text] [Related]
11. Developmental expression of the SRF co-activator MAL in brain: role in regulating dendritic morphology.
Shiota J; Ishikawa M; Sakagami H; Tsuda M; Baraban JM; Tabuchi A
J Neurochem; 2006 Sep; 98(6):1778-88. PubMed ID: 16945101
[TBL] [Abstract][Full Text] [Related]
12. The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF.
Philippar U; Schratt G; Dieterich C; Müller JM; Galgóczy P; Engel FB; Keating MT; Gertler F; Schüle R; Vingron M; Nordheim A
Mol Cell; 2004 Dec; 16(6):867-80. PubMed ID: 15610731
[TBL] [Abstract][Full Text] [Related]
13. The RhoA effector mDiaphanous regulates MyoD expression and cell cycle progression via SRF-dependent and SRF-independent pathways.
Gopinath SD; Narumiya S; Dhawan J
J Cell Sci; 2007 Sep; 120(Pt 17):3086-98. PubMed ID: 17684061
[TBL] [Abstract][Full Text] [Related]
14. Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-β-induced fibrogenesis in human colonic myofibroblasts.
Johnson LA; Rodansky ES; Haak AJ; Larsen SD; Neubig RR; Higgins PD
Inflamm Bowel Dis; 2014 Jan; 20(1):154-65. PubMed ID: 24280883
[TBL] [Abstract][Full Text] [Related]
15. Role of megakaryoblastic acute leukemia-1 in ERK1/2-dependent stimulation of serum response factor-driven transcription by BDNF or increased synaptic activity.
Kalita K; Kharebava G; Zheng JJ; Hetman M
J Neurosci; 2006 Sep; 26(39):10020-32. PubMed ID: 17005865
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activity of megakaryoblastic leukemia 1 (MKL1) is repressed by SUMO modification.
Nakagawa K; Kuzumaki N
Genes Cells; 2005 Aug; 10(8):835-50. PubMed ID: 16098147
[TBL] [Abstract][Full Text] [Related]
17. MAL and ternary complex factor use different mechanisms to contact a common surface on the serum response factor DNA-binding domain.
Zaromytidou AI; Miralles F; Treisman R
Mol Cell Biol; 2006 Jun; 26(11):4134-48. PubMed ID: 16705166
[TBL] [Abstract][Full Text] [Related]
18. Serum response factor activation by muscarinic receptors via RhoA. Novel pathway specific to M1 subtype involving calmodulin, calcineurin, and Pyk2.
Lin K; Wang D; Sadée W
J Biol Chem; 2002 Oct; 277(43):40789-98. PubMed ID: 12200418
[TBL] [Abstract][Full Text] [Related]
19. MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9.
Gilles L; Bluteau D; Boukour S; Chang Y; Zhang Y; Robert T; Dessen P; Debili N; Bernard OA; Vainchenker W; Raslova H
Blood; 2009 Nov; 114(19):4221-32. PubMed ID: 19724058
[TBL] [Abstract][Full Text] [Related]
20. Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation.
Selvaraj A; Prywes R
J Biol Chem; 2003 Oct; 278(43):41977-87. PubMed ID: 14565952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
